Dr. Sara Kalantari is an assistant professor of medicine in the Section of Cardiology specializing in advanced heart failure, cardiac transplantation, and mechanical circulatory support. She is an expert in exercise physiology and is the Director of the Cardiopulmonary Exercise Lab. She founded the Dyspnea Clinic to establish the diagnosis and best treatment course for multifactorial or unexplained dyspnea. She has a strong passion for education and serves as the cardiology section coordinator for the Vignettes in Physiology medical school course as well as the Course Director for the annual Courage and Innovation Symposium for advanced heart failure.
Beyond Thrombosis: Pulmonary Hypertension and Heart Failure in Patients With Myeloproliferative Neoplasms: JACC: CardioOncology State-of-the-Art Review.
Beyond Thrombosis: Pulmonary Hypertension and Heart Failure in Patients With Myeloproliferative Neoplasms: JACC: CardioOncology State-of-the-Art Review. JACC CardioOncol. 2025 Aug; 7(5):538-553.
PMID: 40668166
Mitigating Post-operative Right Ventricular Dysfunction After Left Ventricular Assist Device: The RV Protection Study.
Mitigating Post-operative Right Ventricular Dysfunction After Left Ventricular Assist Device: The RV Protection Study. J Card Fail. 2026 Jan; 32(1):46-57.
PMID: 39954845
Dynamic assessment of left ventricular coupling and myocardial reserve in patients with cardiogenic shock.
Dynamic assessment of left ventricular coupling and myocardial reserve in patients with cardiogenic shock. Eur Heart J Open. 2024 Sep; 4(5):oeae072.
PMID: 39328214
Galectin-3 as a Prognostic Biomarker of Left Ventricular Assist Device Implantation Outcomes.
Galectin-3 as a Prognostic Biomarker of Left Ventricular Assist Device Implantation Outcomes. ASAIO J. 2025 Feb 01; 71(2):136-142.
PMID: 39088729
ATTR Gene Variants in HCM.
ATTR Gene Variants in HCM. JACC Case Rep. 2024 Mar 20; 29(6):102236.
PMID: 38549855
Corrigendum to 'Reverse Remodeling Effects of Sacubitril-Valsartan: Structural and Functional Optimization in Stage C Heart Failure' [American Journal of Cardiology 210 (2024) 249-255].
Corrigendum to 'Reverse Remodeling Effects of Sacubitril-Valsartan: Structural and Functional Optimization in Stage C Heart Failure' [American Journal of Cardiology 210 (2024) 249-255]. Am J Cardiol. 2024 May 01; 218:127.
PMID: 38134968
Adverse Hemodynamic Consequences of Continuous Left Ventricular Mechanical Support: JACC Review Topic of the Week.
Adverse Hemodynamic Consequences of Continuous Left Ventricular Mechanical Support: JACC Review Topic of the Week. J Am Coll Cardiol. 2023 07 04; 82(1):70-81.
PMID: 37380306
Status One and Status Two Exception Use in the Updated Heart Allocation System.
Status One and Status Two Exception Use in the Updated Heart Allocation System. J Card Fail. 2023 06; 29(6):963-967.
PMID: 36966881
The prognostic role of advanced hemodynamic variables in patients with left ventricular assist devices.
The prognostic role of advanced hemodynamic variables in patients with left ventricular assist devices. Artif Organs. 2023 Mar; 47(3):574-581.
PMID: 36305735
Postoperative tolvaptan use in left ventricular assist device patients: The TOLVAD randomized pilot study.
Postoperative tolvaptan use in left ventricular assist device patients: The TOLVAD randomized pilot study. Artif Organs. 2022 Dec; 46(12):2382-2390.
PMID: 36574590